News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

Pfizer and BioNTech say coronavirus vaccine has 90% efficacy rate and could be rolled out this year

Pfizer and BioNTech say they could manufacture 50m doses of coronavirus vaccine this year

Pfizer and BioNTech say coronavirus vaccine has 90% efficacy rate and could be rolled out this year
Photo: Jakub Porzycki//Getty Images

Drug companies Pfizer and BioNTech have said that their BNT162b2 coronavirus vaccine showed 90% efficacy against Covid-19 in testing and could be rolled out this year.

The US and German drug companies said they expect to produce up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021.

WSJ Logo